Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications

Overview

Journal Genet Res Int

Date 2012 Aug 2

PMID 22852089

Citations 48

Authors

Katey S S Enfield

Larissa A Pikor

Victor D Martinez

Wan L Lam

Affiliations

Soon will be listed here.

Abstract

Lung cancer biology has traditionally focused on genomic and epigenomic deregulation of protein-coding genes to identify oncogenes and tumor suppressors diagnostic and therapeutic targets. Another important layer of cancer biology has emerged in the form of noncoding RNAs (ncRNAs), which are major regulators of key cellular processes such as proliferation, RNA splicing, gene regulation, and apoptosis. In the past decade, microRNAs (miRNAs) have moved to the forefront of ncRNA cancer research, while the role of long noncoding RNAs (lncRNAs) is emerging. Here we review the mechanisms by which miRNAs and lncRNAs are deregulated in lung cancer, the technologies that can be applied to detect such alterations, and the clinical potential of these RNA species. An improved comprehension of lung cancer biology will come through the understanding of the interplay between deregulation of non-coding RNAs, the protein-coding genes they regulate, and how these interactions influence cellular networks and signalling pathways.

Citing Articles

The regulatory role and therapeutic potential of long non-coding RNA in non-small cell lung cancer.

Xia S, Lu X, Wang W, Pan X, Cui J, Wang S J Cancer. 2025; 16(4):1137-1148.

PMID: 39895777 PMC: 11786035. DOI: 10.7150/jca.103182.

Deciphering the role of NcRNAs in Pancreatic Cancer immune evasion and drug resistance: a new perspective for targeted therapy.

Gong Y, Gong D, Liu S, Gong X, Xiong J, Zhang J Front Immunol. 2024; 15:1480572.

PMID: 39555076 PMC: 11563824. DOI: 10.3389/fimmu.2024.1480572.

Association between long noncoding RNA rs944289 and rs7990916 polymorphisms and the risk of colorectal cancer in a Chinese population.

Wang Y, Qiu Z, Tian G, Zhu Q, Zhang Z, Qin R Sci Rep. 2022; 12(1):2495.

PMID: 35169218 PMC: 8847648. DOI: 10.1038/s41598-022-06474-3.

Clinicopathological implications of lncRNAs, immunotherapy and DNA methylation in lung squamous cell carcinoma: a narrative review.

Sasa G, Xuan C, Chen M, Jiang Z, Ding X Transl Cancer Res. 2022; 10(12):5406-5429.

PMID: 35116387 PMC: 8799054. DOI: 10.21037/tcr-21-1607.

TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction.

Li X, Liu L, Song X, Wang K, Niu L, Xie L J Cancer Res Clin Oncol. 2021; 147(6):1609-1622.

PMID: 33792796 DOI: 10.1007/s00432-020-03502-5.

References

Machado-Lima A, Del Portillo H, Durham A . Computational methods in noncoding RNA research. J Math Biol. 2007; 56(1-2):15-49. DOI: 10.1007/s00285-007-0122-6. View

Gibb E, Enfield K, Stewart G, Lonergan K, Chari R, Ng R . Long non-coding RNAs are expressed in oral mucosa and altered in oral premalignant lesions. Oral Oncol. 2011; 47(11):1055-61. DOI: 10.1016/j.oraloncology.2011.07.008. View

Enfield K, Stewart G, Pikor L, Alvarez C, Lam S, Lam W . MicroRNA gene dosage alterations and drug response in lung cancer. J Biomed Biotechnol. 2011; 2011:474632. PMC: 3085440. DOI: 10.1155/2011/474632. View

Gorodkin J, Hofacker I . From structure prediction to genomic screens for novel non-coding RNAs. PLoS Comput Biol. 2011; 7(8):e1002100. PMC: 3150283. DOI: 10.1371/journal.pcbi.1002100. View

Iorio M, Croce C . MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009; 27(34):5848-56. PMC: 2793003. DOI: 10.1200/JCO.2009.24.0317. View

Muniyappa M, Dowling P, Henry M, Meleady P, Doolan P, Gammell P . MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer. 2009; 45(17):3104-18. DOI: 10.1016/j.ejca.2009.09.014. View

Harfe B . MicroRNAs in vertebrate development. Curr Opin Genet Dev. 2005; 15(4):410-5. DOI: 10.1016/j.gde.2005.06.012. View

Rivas E, Eddy S . Noncoding RNA gene detection using comparative sequence analysis. BMC Bioinformatics. 2002; 2:8. PMC: 64605. DOI: 10.1186/1471-2105-2-8. View

Nasser M, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S . Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem. 2008; 283(48):33394-405. PMC: 2586284. DOI: 10.1074/jbc.M804788200. View

10.

Sczyrba A, Kruger J, Mersch H, Kurtz S, Giegerich R . RNA-related tools on the Bielefeld Bioinformatics Server. Nucleic Acids Res. 2003; 31(13):3767-70. PMC: 168982. DOI: 10.1093/nar/gkg576. View

11.

Saunders M, Liang H, Li W . Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A. 2007; 104(9):3300-5. PMC: 1805605. DOI: 10.1073/pnas.0611347104. View

12.

Garzon R, Marcucci G, Croce C . Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010; 9(10):775-89. PMC: 3904431. DOI: 10.1038/nrd3179. View

13.

Yu S, Chen H, Chang G, Chen C, Chen H, Singh S . MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008; 13(1):48-57. DOI: 10.1016/j.ccr.2007.12.008. View

14.

Cabili M, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A . Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011; 25(18):1915-27. PMC: 3185964. DOI: 10.1101/gad.17446611. View

15.

Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M . The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res. 2007; 67(4):1419-23. DOI: 10.1158/0008-5472.CAN-06-4074. View

16.

Lim L, Lau N, Weinstein E, Abdelhakim A, Yekta S, Rhoades M . The microRNAs of Caenorhabditis elegans. Genes Dev. 2003; 17(8):991-1008. PMC: 196042. DOI: 10.1101/gad.1074403. View

17.

Wapinski O, Chang H . Long noncoding RNAs and human disease. Trends Cell Biol. 2011; 21(6):354-61. DOI: 10.1016/j.tcb.2011.04.001. View

18.

Lu C, Tej S, Luo S, Haudenschild C, Meyers B, Green P . Elucidation of the small RNA component of the transcriptome. Science. 2005; 309(5740):1567-9. DOI: 10.1126/science.1114112. View

19.

Gallardo E, Navarro A, Vinolas N, Marrades R, Diaz T, Gel B . miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis. 2009; 30(11):1903-9. DOI: 10.1093/carcin/bgp219. View

20.

John B, Enright A, Aravin A, Tuschl T, Sander C, Marks D . Human MicroRNA targets. PLoS Biol. 2004; 2(11):e363. PMC: 521178. DOI: 10.1371/journal.pbio.0020363. View